NCT03873883 2024-09-19
IO-001
iTeos Therapeutics
Phase 1 Completed
iTeos Therapeutics
Renmin Hospital of Wuhan University
Taichung Tzu Chi Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Oncolytics Biotech
Aduro Biotech, Inc.
Yonsei University
University of Utah